Related Experiment Video
Updated: Mar 19, 2026
The Drosophila Imaginal Disc Tumor Model: Visualization and Quantification of Gene Expression and Tumor Invasiveness Using Genetic Mosaics
Published on: October 6, 2016
Cancer Drug Development Using Drosophila as an in vivo Tool: From Bedside to Bench and Back
Amarish Kumar Yadav1, Saripella Srikrishna1, Subash Chandra Gupta2
1Cancer and Neurobiology Laboratory, Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi 221 005, India.
Abstract:
The fruit fly Drosophila melanogaster has been used for modeling cancer and as an in vivo tool for the validation and/or development of cancer therapeutics. The impetus for the use of Drosophila in cancer research stems from the high conservation of its signaling pathways, lower genetic redundancy, short life cycle, genetic amenability, and ease of maintenance. Several cell signaling pathways in Drosophila have been used for cancer drug development. The efficacy of combination therapy and uptake/bioavailability of drugs have also been studied. Drosophila has been validated using several FDA-approved drugs, suggesting a potential application of this model in drug repurposing. The model is emerging as a powerful tool for high-throughput screening and should significantly reduce the cost and time associated with drug development. In this review we discuss the applications of Drosophila in cancer drug development. The advantages and limitations of the model are discussed.
Insights
Fruit flies (Drosophila melanogaster) offer a powerful, cost-effective model for cancer research and drug development due to conserved pathways and rapid life cycles. This model aids in high-throughput screening and drug repurposing, accelerating therapeutic discovery.
Area of Science:
- * Oncology
- * Genetics
- * Pharmacology
Background:
- * The fruit fly *Drosophila melanogaster* serves as a valuable model organism in cancer research.
- * Its utility stems from conserved signaling pathways, reduced genetic redundancy, and ease of manipulation.
- * This model facilitates the study of cancer and the development of novel therapeutics.
Purpose of the Study:
- * To review the applications of *Drosophila melanogaster* in cancer drug development.
- * To highlight its role in validating and developing cancer therapeutics.
- * To discuss the advantages and limitations of using this model.
Main Methods:
- * Utilizing conserved cell signaling pathways for cancer drug development.
- * Investigating the efficacy of combination therapies.
- * Assessing drug uptake and bioavailability in vivo.
Main Results:
- * *Drosophila* models have been validated with FDA-approved drugs, indicating potential for drug repurposing.
- * The model supports high-throughput screening, reducing drug development costs and timelines.
- * Several cell signaling pathways in *Drosophila* have been successfully employed for therapeutic studies.
Conclusions:
- * *Drosophila melanogaster* is an emerging, powerful tool for accelerating cancer therapeutic development.
- * Its application in high-throughput screening and drug repurposing offers significant advantages.
- * The model provides a cost-effective and efficient platform for preclinical cancer research.
More Related Videos
Related Concept Videos
02:43Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:46Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...